Skip to main content
Home

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Rendered image depicting vials of corticosteroid drug dexamethasone
Rendered image depicting vials of corticosteroid drug dexamethasone digicomphoto DepositPhotos Deposit Photos
Health
Covid-19
Coronavirus
Dexamethasone
anti-inflammatory
corticosteroid
intensive care
intensive care unit
European Medicines Agency
Medicines Evaluation Board
Dexamethasone Taw
Taw Pharma
United Kingdom
Marc Bonten
UMC Utrecht
NVIC
Diederik Gommers
Thursday, September 3, 2020 - 14:30
Share this:
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • reddit

Covid-19 drug treatment evaluated by EMA & Dutch regulator

A name brand version of a cheap and widely available anti-inflammatory steroid will be assessed by the European Medicines Agency (EMA) to determine if it can be recommended as a treatment option for adult patients suffering from Covid-19. The EMA said on Wednesday it would evaluate the drug, Dexamethasone Taw, using an accelerated procedure which will take 150 days instead of 210.

Its use was also being researched by the Dutch Medicines Evaluation Board, according to AD, which previously evaluated remdesivir, an anti-viral intravenous drug originally developed to treat symptoms from an Ebola virus infection.

The application was filed by Taw Pharma in the United Kingdom following Oxford University research which showed that use of generic dexamethasone reduced the chance of death by about 30 percent among Covid-19 patients requiring a ventilator, according to the EMA. Those requiring oxygen, but not a ventilator, had a 20 percent improved survival rate when using the drug. Over 5,400 patients were involved in the study, which was published in the journal Recovery.

Dexamethasone was also used experimentally at the UMC Utrecht, and that it was becoming more common in treatment of the coronavirus disease. "In the research group that we are a part of we had decided on Wednesday evening to stop with other steroid treatments," microbiologist Dr. Marc Bonten told NL Times in June. Of patients on the drug, he said, “It helps to suppress their immunity. We think that a large number of patients were getting sicker because of their own immune response."

"When people take that, they are less likely to end up in ICU, and they need less oxygen in the regular hospital ward," said Diederik Gommers of the Dutch intensive care association NVIC. "With us, the medicine is already standard in the treatment protocol. You could even start with it if people are still at home, if the blood test shows that they can benefit from it," he told newspaper AD in July.

"Before receiving this application, the [Committee for Medicinal Products for Human Use] had started reviewing the results of the Recovery trial in order to provide an opinion on the use of dexamethasone medicines for COVID-19," the EMA said. "The outcome of this review will be considered in the evaluation of Dexamethasone Taw."

If approved, the EMA would also look to fast-track authorization to use the branded version of the drug with the European Commission. Dexamethasone Taw would be sold as an injectable medicine. Other dexamethasone products are sold as tablets and in liquids meant to be administered intravenously.

Follow us:

Latest stories

  • Dutch could reopen cafe terraces, universities in three weeks: Report
  • ChristenUnie wants five-day mandatory reflection period before abortion, even in case of rape
  • Angry fishers dump rocks in front to Greenpeace headquarters
  • Suspects in fatal parking garage shooting in Amsterdam sentenced to 7 and 11 years in prison
  • 'Larges Dutch criminal investigation' finds corruption among Amsterdam police
  • Coronavirus infections set new six-week high; hospitalizations up 3 percent for the week

Top Stories

  • Dutch could reopen cafe terraces, universities in three weeks: Report
  • 'Larges Dutch criminal investigation' finds corruption among Amsterdam police
  • Coronavirus infections set new six-week high; hospitalizations up 3 percent for the week
  • Covid restrictions in nursing homes may be relaxed on Monday: Report
  • Dutch compliance with coronavirus measures seems to be declining, says van Dissel
  • Over 1.5 million covid vaccines given; New infection see-saw continues

© 2012-2021 NLTimes.nl, All rights reserved.

Footer menu

  • Privacy
  • Contact